List of works - Sara Bravaccini

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance

scientific article published in February 2015

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

scientific article published on 01 January 2020

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

scientific article published on 10 March 2015

Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients

scientific article published on 01 October 2009

Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?

scientific article published on 27 August 2018

Are we ready to use TMB in breast cancer clinical practice?

scientific article published on 28 July 2020

Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.

scientific article

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

scientific article

Biofunctional characteristics of in situ and invasive breast carcinoma.

scientific article

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

scientific article published on 03 April 2019

Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling

scientific article published on 22 January 2020

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

scientific article published on 01 January 2020

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

scientific article published on 21 February 2011

Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches

scientific article published on 29 October 2011

Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT).

scientific article

Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations

scientific article published in May 2014

Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression

scientific article published on 01 February 2019

Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa

scientific article published on 13 November 2019

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

scientific article published on 14 April 2019

Explaining the aggressiveness of breast cancer in sub-Saharan African patients

scientific article published on 13 August 2019

Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?

scientific article

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

scientific article published on 08 August 2020

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy

scientific article

Microbiota-Derived Metabolites in Tumor Progression and Metastasis

scientific article published on 12 August 2020

Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue

scientific article published on 26 March 2013

New biomarkers to predict the evolution of in situ breast cancers

scientific article

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

scientific article published on December 2015

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer

scientific article

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

scientific article published on 17 February 2016

Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

scientific article published on 21 September 2018

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

scientific article published on 26 August 2015

Potential of telomerase expression and activity in cervical specimens as a diagnostic tool

scientific article published on September 2005

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.

scientific article

Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.

scientific article

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells

scientific article (publication date: October 2005)

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

scientific article published in The Journal of the American Medical Association

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast

scientific article published on 11 November 2015

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy

scientific article published on 02 September 2019

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

scientific article published on 05 July 2011

The current role of telomerase in the diagnosis of bladder cancer

scientific article published on January 2009

Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients ⬇️

scientific article

Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential

scientific article published on June 2012

Urine Telomerase Activity for the Detection of Bladder Cancer in Females

scientific article published on 11 May 2007

Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data

scientific article

Urine telomerase: an important marker in the diagnosis of bladder cancer

scientific article

Usefulness of immunological detection of the human telomerase reverse transcriptase

scientific article

What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?

scientific article published on 01 January 2020

What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?

scientific article published on 11 March 2019

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

scientific article published on 22 May 2019

What to look for in cell-free DNA from breast cancer patients

scientific article published on 26 February 2018

List of works by Sara Bravaccini

111In-Pentetreotide (OctreoScan) scintigraphy in the staging of small-cell lung cancer: its accuracy and prognostic significance

ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients

ALK translocation detection in non-small cell lung cancer cytological samples obtained by TBNA or EBUS-TBNA.

Accuracy of urine telomerase activity to detect bladder cancer in symptomatic patients

Are fine-needle aspiration biopsy-derived cell blocks a useful surrogate for tissue samples in breast cancer?

Are we ready to use TMB in breast cancer clinical practice?

Assessment of DNA damage and telomerase activity in exfoliated urinary cells as sensitive and noninvasive biomarkers for early diagnosis of bladder cancer in ex-workers of a rubber tyres industry.

Benefit from anthracyclines in relation to biological profiles in early breast cancer.

Biofunctional characteristics of in situ and invasive breast carcinoma.

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Carbonic Anhydrase XII Expression Is Modulated during Epithelial Mesenchymal Transition and Regulated through Protein Kinase C Signaling

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

Clinical utility of fulvestrant in the treatment of breast cancer: a report on the emerging clinical evidence

Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients

Detection of HER2 and Topo 2 in breast cancers: comparison between MLPA and FISH approaches

Development and characterization of a monoclonal antibody directed against human telomerase reverse transcriptase (hTERT).

Differences in biological features of breast cancer between Caucasian (Italian) and African (Tanzanian) populations

Epithelial-to-mesenchymal transition and EGFR status in NSCLC: the role of vimentin expression

Evaluating the appropriateness of chemotherapy in a low-resource cancer centre in sub-Saharan Africa

Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

Explaining the aggressiveness of breast cancer in sub-Saharan African patients

Is Ki67 still a powerful ally in predicting the clinical benefit of anthracyclines for the adjuvant treatment of early breast cancer?

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

Long-term complete response in a patient with liver metastases from breast cancer treated with metronomic chemotherapy

Microbiota-Derived Metabolites in Tumor Progression and Metastasis

Molecular determinations of EGFR and EML4-ALK on a single slide of NSCLC tissue

New biomarkers to predict the evolution of in situ breast cancers

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer

Paraneoplastic lipase and amylase production in a patient with small-cell lung cancer: case report

Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

Potential of telomerase expression and activity in cervical specimens as a diagnostic tool

Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.

Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CIN.

Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

Role of androgen and estrogen receptors as prognostic and potential predictive markers of ductal carcinoma in situ of the breast

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy

The Role of CXCR4 in the Prediction of Bone Metastases from Breast Cancer: A Pilot Study

The current role of telomerase in the diagnosis of bladder cancer

Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients ⬇️

Urinary biomarkers of non-muscle-invasive bladder cancer: current status and future potential

Urine Telomerase Activity for the Detection of Bladder Cancer in Females

Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data

Urine telomerase: an important marker in the diagnosis of bladder cancer

Usefulness of immunological detection of the human telomerase reverse transcriptase

What Influences the Choice of Ibrutinib-Rituximab vs Classic Chemoimmunotherapy for Chronic Lymphocytic Leukemia?

What impacts the cost-effectiveness of PD-L1 testing in non-small cell lung cancer?

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

What to look for in cell-free DNA from breast cancer patients